Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Alpha Tau Medical Ltd (DRTS)

52 + Investors. Track Smart Money conviction in DRTS. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +17
Streak
3Q ▲
Buyers last Q
65%

Smart Money Signals — DRTS

Based on 52 hedge funds · latest filing: 2026 Q1 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added DRTS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
52 hedge funds hold DRTS right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +126% more funds vs a year ago

fund count last 6Q
+29 new funds entered over the past year (+126% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks.
🟢

More buyers than sellers — 65% buying

28 buying15 selling
Last quarter: 28 funds were net buyers (19 opened a brand new position + 9 added to an existing one). Only 15 were sellers (13 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+10 vs last Q)

new funds entering per quarter
Funds opening a new DRTS position: 3 → 10 → 9 → 19. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
📌

Mixed — 37% long-term, 54% new

■ 37% conviction (2yr+) ■ 10% medium ■ 54% new
Of the 52 current holders: 19 (37%) held >2 years, 5 held 1–2 years, and 28 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.
💰

Value +167% but shares only +85% — price-driven

Value
+166%
Shares
+84%
Last quarter: the total dollar value of institutional holdings rose +167%, but actual share count only changed +85%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

5 → 3 → 10 → 9 → 19 new funds/Q
New funds entering each quarter: 3 → 10 → 9 → 19. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🌱

Early stage — 57% of holders entered in last year

■ 38% veterans ■ 5% 1-2yr ■ 57% new
Of 56 current holders: 32 (57%) entered in the past year, only 21 (38%) are 2+ year veterans. This is an early-phase institutional idea — still being discovered. High upside potential if the thesis plays out, but thin conviction base.
📋

Smaller funds dominant — 18% AUM from top-100

18% from top-100 AUM funds
16 of 52 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
5.7
out of 10
Moderate Exit Risk
Exit risk score 5.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — DRTS

In 2026 Q1, 28 hedge funds were net buyers of DRTS (19 opened a new position, 9 added to an existing one), while 15 reduced or exited (13 trimmed, 2 sold completely) — a 65% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. Net fund flow last quarter: +17 funds (more new holders than closures). Total institutional holders: 52.

Hedge Fund Ownership: DRTS

How many hedge funds hold DRTS — quarterly history vs. share price
Quarterly hedge fund ownership of DRTS vs. share price

Market Analysis: DRTS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: DRTS

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Alpha Tau Medical Ltd (DRTS) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much DRTS has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 81d ago
DRTS
+38.3%
XLV
+2.1%

DRTS outperformed XLV by +36.2% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 36d ago
DRTS
-5.6%
XLV
+3.2%

Since the filing became public, DRTS outperformed XLV by -8.8% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

5 top-rated funds 0 high-conviction
Consensus
3.4
/ 10
breadth
×
Elite
0.5
/ 10
conviction
Hedge Fund Positioning: DRTS
52 + Investors

Track Smart Money conviction in DRTS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 52 35 48.57%
13F Shares 4M 2M 84.89%
Total Value $30M $11M 166.94%
New Positions 19 9 +10
Increased Positions 9 5 +4
Closed Positions 2 5 -3
Reduced Positions 13 8 +5
Total Calls 3 0 100%
Total Puts 1 1 -
PUT/CALL Ratio 0.33 0.0 Bullish

Statistics: DRTS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

52 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in DRTS. Verified SEC 13F-HR filings.

QUARTER:
Top 25 DRTS holders by conviction (% of portfolio weight) — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Daytona Street Capital LLC 0.80% 146,106 $1.0M
2 Gem Investment Advisors, LLC 0.79% 113,736 $804K
3 Aquamarine Financial (Cayman) Ltd 0.37% 721,501 $5.1M
4 Levin Capital Strategies, L.P. 0.06% 106,423 $752K
5 Financial Guidance Group, Inc. 0.06% 20,000 $141K
6 Satovsky Asset Management LLC 0.05% 40,706 $288K
7 Apella Capital, LLC 0.05% 382,284 $3.1M
8 NorthCoast Asset Management LLC 0.02% 147,138 $1.0M
9 Tower View Wealth Management LLC 0.02% 5,566 $39K
10 ARK Investment Management LLC 0.02% 292,134 $2.1M
11 Opal Wealth Advisors, LLC 0.02% 10,000 $71K
12 Woodstock Corp 0.01% 20,609 $146K
13 Trifecta Capital Advisors, LLC 0.01% 9,700 $69K
14 Caitlin John, LLC 0.01% 1,765 $12K
15 HighTower Advisors, LLC 0.01% 874,994 $6.2M
16 Summit Financial, LLC 0.00% 30,000 $212K
17 XTX Topco Ltd 0.00% 19,019 $134K
18 Private Advisor Group, LLC 0.00% 47,583 $336K
19 Private Wealth Management Group, LLC 0.00% 752 $5K
20 Mariner, LLC 0.00% 146,396 $1.0M
21 Aptus Capital Advisors, LLC 0.00% 20,000 $141K
22 Renaissance Technologies LLC 0.00% 40,457 $286K
23 Tidal Investments LLC 0.00% 25,093 $177K
24 Cerity Partners LLC 0.00% 32,012 $226K
25 Equitable Holdings, Inc. 0.00% 10,000 $50K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Alpha Tau Medical Ltd (DRTS)

What does the Smart Money Trend signal show for DRTS?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added DRTS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for DRTS?

More buyers than sellers — 65% buying: Last quarter: 28 funds were net buyers (19 opened a brand new position + 9 added to an existing one). Only 15 were sellers (13 trimmed + 2 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for DRTS holders?

Smaller funds dominant — 18% AUM from top-100: 16 of 52 holders rank in the top 100 by AUM, but together hold only 18% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held DRTS?

Mixed — 37% long-term, 54% new: Of the 52 current holders: 19 (37%) held >2 years, 5 held 1–2 years, and 28 entered in the last year. A mixed base — the stock has long-term believers but also recent buyers who haven't been tested by a downturn yet.

Is it too late to buy Alpha Tau Medical Ltd (DRTS) following the 2026 Q1 hedge fund 13F filings?

As of today, DRTS has moved -5.6% since the 2026 Q1 13F filing date (May 15, 2026), compared to +3.2% for the XLV sector ETF — an outperformance of -8.8%. Since the quarter end (March 31, 2026), DRTS has gained +38.3% vs +2.1% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →